Pulmonary Artery Sarcoma Overexpressing Platelet-derived Growth Factor Receptor α

Por Takemoto, Shinnosuke, Soda, Hiroshi, Iwasaki, Keisuke, Kitazaki, Takeshi, Sumiyoshi, Makoto, Harada, Tatsuhiko, Dotsu, Yosuke, Ogawara, Daiki, Fukahori, Susumu, Fukuda, Yuichi, Mukae, Hiroshi
Publicado no Intern Med (2017)

Phase I study of pemetrexed and concurrent radiotherapy for previously untreated elderly patients with locally advanced non‐squamous non‐small cell lung cancer

Por Takemoto, Shinnosuke, Nakamura, Yoichi, Fukuda, Minoru, Senju, Hiroaki, Gyotoku, Hiroshi, Taniguchi, Hirokazu, Shimada, Midori, Ikeda, Takaya, Yamaguchi, Hiroyuki, Nakatomi, Katsumi, Hayashi, Nobuyuki, Soda, Hiroshi, Mukae, Hiroshi
Publicado no Thorac Cancer (2017)

Relationship between UGT1A1*27 and UGT1A1*7 polymorphisms and irinotecan‐related toxicities in patients with lung cancer

Por Fukuda, Minoru, Okumura, Manabu, Iwakiri, Tomomi, Arimori, Kazuhiko, Honda, Takuya, Kobayashi, Kazuma, Senju, Hiroaki, Takemoto, Shinnosuke, Ikeda, Takaya, Yamaguchi, Hiroyuki, Nakatomi, Katsumi, Matsuo, Nobuko, Mukae, Hiroshi, Ashizawa, Kazuto
Publicado no Thorac Cancer (2017)

Phase II trial of a non‐platinum triplet for patients with advanced non‐small cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNA

Por Takemoto, Shinnosuke, Nakamura, Yoichi, Gyoutoku, Hiroshi, Senju, Hiroaki, Ogawara, Daiki, Ikeda, Takaya, Yamaguchi, Hiroyuki, Kitazaki, Takeshi, Nakano, Hirofumi, Nakatomi, Katsumi, Tomari, Shinya, Sato, Shuntaro, Nagashima, Seiji, Fukuda, Minoru, Mukae, Hiroshi
Publicado no Thorac Cancer (2019)

Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study

Por Ikeda, Takaya, Takemoto, Shinnosuke, Senju, Hiroaki, Gyotoku, Hiroshi, Taniguchi, Hirokazu, Shimada, Midori, Dotsu, Yosuke, Umeyama, Yasuhiro, Tomono, Hiromi, Kitazaki, Takeshi, Fukuda, Masaaki, Soda, Hiroshi, Yamaguchi, Hiroyuki, Fukuda, Minoru, Mukae, Hiroshi
Publicado no Thorac Cancer (2020)

Dabrafenib and trametinib therapy in an elderly patient with non‐small cell lung cancer harboring the BRAF V600E mutation

Por Dotsu, Yosuke, Fukuda, Minoru, Honda, Noritaka, Gyotoku, Hiroshi, Kohno, Yoshihisa, Suyama, Takayuki, Umeyama, Yasuhiro, Taniguchi, Hirokazu, Takemoto, Shinnosuke, Yamaguchi, Hiroyuki, Miyazaki, Taiga, Sakamoto, Noriho, Obase, Yasushi, Ikeda, Hiroaki, Ashizawa, Kazuto, Mukae, Hiroshi
Publicado no Thorac Cancer (2020)

Phase II study of ramucirumab and docetaxel for previously treated non‐small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study

Por Takemoto, Shinnosuke, Fukuda, Minoru, Yamaguchi, Hiroyuki, Ikeda, Takaya, Akagi, Kazumasa, Tomono, Hiromi, Umeyama, Yasuhiro, Dotsu, Yosuke, Taniguchi, Hirokazu, Gyotoku, Hiroshi, Senju, Hiroaki, Kitazaki, Takeshi, Nakatomi, Katsumi, Nagashima, Seiji, Fukuda, Masaaki, Kinoshita, Akitoshi, Soda, Hiroshi, Mukae, Hiroshi
Publicado no Thorac Cancer (2019)

Phase II study of nedaplatin and amrubicin as first‐line treatment for advanced squamous cell lung cancer

Por Taniguchi, Hirokazu, Yamaguchi, Hiroyuki, Dotsu, Yosuke, Shimada, Midori, Gyotoku, Hiroshi, Senju, Hiroaki, Takemoto, Shinnosuke, Kitazaki, Takeshi, Fukuda, Masaaki, Ogawara, Daiki, Soda, Hiroshi, Nakatomi, Katsumi, Sugasaki, Nanae, Kinoshita, Akitoshi, Nagashima, Seiji, Ikeda, Takaya, Nakamura, Yoichi, Sakamoto, Noriho, Obase, Yasushi, Fukuda, Minoru, Mukae, Hiroshi
Publicado no Thorac Cancer (2019)